NSE › Healthcare

Thyrocare Technologies Limited (THYROCARE)

NSE · Healthcare · Diagnostics & Research

₹592.55+2.34%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹224 cr
Revenue YoY
+19.7%
Net profit
₹47 cr
Profit YoY
+117.1%
EPS
₹2.98
EPS estimate
₹5.40
Net margin
21.0%

EPS came in at 2.98 against a street estimate of 5.40 — a miss of 44.8%.

Key statistics

Market cap
₹9,200 cr
P/E
52.3
Forward P/E
0.0
P/B
15.74
Book value
₹36.79
EPS (TTM)
₹11.06
52-week high
₹987,151.25
52-week low
₹338.15
50-day MA
₹537.68
200-day MA
₹455.79
Beta
0.47

Analyst view

with an average price target of ₹649.00.

Shareholding

Promoters
61.09%
Institutions
21.47%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Thyrocare Technologies Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.